| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |